EARNINGS (LOSS) PER SHARE - Narrative (Details) - $ / shares |
3 Months Ended | |
|---|---|---|
Mar. 31, 2026 |
Mar. 31, 2025 |
|
| EARNINGS (LOSS) PER SHARE | ||
| Number of warrants exercised (in shares) | 0 | 200,000 |
| Employee Stock Option | ||
| EARNINGS (LOSS) PER SHARE | ||
| Antidilutive securities not included in computation of diluted loss per share (in shares) | 14,700,000 | 6,800,000 |
| Warrant | ||
| EARNINGS (LOSS) PER SHARE | ||
| Antidilutive securities not included in computation of diluted loss per share (in shares) | 4,700,000 | 4,700,000 |
| Exercise price of warrants (in dollars per share) | $ 3.77 | |
| Number of shares of common stock entitled from warrants (in shares) | 500,000 | |
| X | ||||||||||
- Definition Number of warrants exercised. No definition available.
|
| X | ||||||||||
- Definition Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|